Pressbee - Medscape :
Watch the post from Negative Antiamyloid Drug Trial: Lessons Learned, Now to the details :
Although crenezumab was not superior to placebo in individuals who are at high risk for Alzheimer's disease in the API ADAD Colombia Trial, results provide important data for future studies, experts say.
Medscape Medical News
For more, read the news from the source
Negative Antiamyloid Drug Trial: Lessons Learned
This was the summery for Negative Antiamyloid Drug Trial: Lessons Learned We hope that we have succeeded by sharing the full details of this topic.
Medscape Negative Antiamyloid Drug Trial: Lessons Learned Although crenezumab was not superior to placebo in individuals who are at high risk for Alzheimer's disease in the API ADAD Colombia Trial, results provide important data for future studies, experts say.Medscape Medical News
Please note that the original topic has been published and is available on Medscape the editing team at PressBee have verified it and it may have been partially modified or quoted from it. You can read and follow this news or topic from its main source.
